Compound Focus, a subsidiary of BioFocus, has signed a three-year compound management services agreement with Lundbeck Research.

The company will manage Lundbeck’s liquid chemical collection, distributing screening sets to high-throughput screening centres in the US and Europe from its facility in San Francisco, California.

Lundbeck Research is engaged in drug discovery aimed at treating patients with psychiatric and neurological disorders by designing small molecule therapeutics.

Compound Focus general manager Scott Snyder said that he was pleased to welcome Lundbeck Research as a new client.

“Compound Focus continues to attract commercial, government and charitable organisations that see our state-of-the-art automation and compound management experience as a complement to their discovery operations,” he added.